Your search for major depressive disorder returned 23 results

Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.

Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.

Investigators from Texas Tech University searched publication databases for studies evaluating risk for diabetes mellitus, hypertension, dyslipidemia, and atherosclerotic macrovascular disease in the setting of ASD.

The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.

Investigators searched publication databases for studies that evaluated the association between childhood maltreatment and mental health outcomes.

The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.

Children and adolescents were evaluated for receipt of antipsychotics between 2000 and 2019 in England.

Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.

Electronic health records from 77 health care organizations in the US were evaluated for a risk for endocarditis among patients with opioid use disorder or cocaine use disorder on the basis of contracting COVID-19.

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.

Researchers sought to develop a patient-centered COS for QOL evaluation in clinical practice for adults with drug-resistant epilepsy.

Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.

Researchers measured associations between trauma and child psychiatric disorders in a birth cohort in Brazil.

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Researchers sought to assess the impact of early vs late initiation of natalizumab by looking at clinical and imaging information of patients with MS.

Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.

Researchers sought to assess the impact of the COVID-19 pandemic on sleep in children with neurodevelopmental disorders and insomnia symptoms, and identify the factors that led to changes in sleep habits.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

Researchers investigated whether lurasidone monotherapy would improve health-related quality of life.

Researchers investigated whether there were identifiable treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.

Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.